Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016..
Data from: Nitroglycerin in non-small cell lung cancer: does it impact tumor hypoxia and tumor perfusion? A window-of-opportunity clinical trial. 2016..
Data from: Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – a survival model with external validation. 2016..
Data from: Quantitative assessment of Zirconium-89 labeled cetuximab using PETCT imaging in patients with advanced head and neck cancer - a theragnostic approach. 2016..
From Data to Decision - A Knowledge Engineering approach to individualise cancer therapy. GROW - School for Oncology and Developmental Biology. [Maastricht]: Maastricht University; 2016. p. 175..
Data from: A validated Tumor Control Probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy [Internet]. 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.8.
Data from: Development and Evaluation of an Online Three-Level Proton vs Photon Decision Support Prototype for Head and Neck Cancer - Comparison of Dose, Toxicity and Cost-Effectiveness [Internet]. CancerData; 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.5.
Data from: MMP2 small immuno protein antibody uptake in xenograft tumors is associated with MMP2 activity [Internet]. CancerData; 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.6.
PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol. 2015;116(2):281-6..
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. Int J Radiat Oncol Biol Phys. 2015;92(4):935-44..
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006..
Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. Radiother Oncol. 2014;113(3):324-30..
International data-sharing for radiotherapy research: an open-source based infrastructure for multicentric clinical data mining. Radiother Oncol. 2014;110(2):370-4..
Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. Radiotherapy and Oncology [Internet]. 2013;108(1):174 - 179. http://linkinghub.elsevier.com/retrieve/pii/S0167814012004446.
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiotherapy and Oncology [Internet]. 2013;109(1):100 - 106. http://linkinghub.elsevier.com/retrieve/pii/S0167814013004350.
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. Radiotherapy and Oncology [Internet]. 2012;102(3):436 - 443. http://linkinghub.elsevier.com/retrieve/pii/S016781401200059X.
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proceedings of the National Academy of Sciences [Internet]. 2011;108(35):14620 - 14625. http://www.pnas.org/cgi/doi/10.1073/pnas.1102526108.
PET imaging of hypoxia using [18F]HX4: a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging [Internet]. 2010;37(9):1663 - 1668. http://link.springer.com/10.1007/s00259-010-1437-x.